Literature DB >> 17350940

Intensity modulating and other radiation therapy devices for dose painting.

James M Galvin1, Wilfried De Neve.   

Abstract

The introduction of intensity-modulated radiation therapy (IMRT) in the early 1990s created the possibility of generating dramatically improved dose distributions that could be tailored to fit a complex geometric arrangement of targets that push against or even surround healthy critical structures. IMRT is a new treatment paradigm that goes beyond the capabilities of the earlier technology called three-dimensional radiation therapy (3DCRT). IMRT took the older approach of using fields that conformed to the silhouette of the target to deliver a relatively homogeneous intensity of radiation and separated the conformal fields into many subfields so that intensity could be varied to better control the final dose distribution. This technique makes it possible to generate radiation dose clouds that have indentations in their surface. Initially, this technology was mainly used to avoid and thus control the dose delivered to critical structures so that they are not seriously damaged in the process of irradiating nearby targets to an appropriately high dose. Avoidance of critical structures allowed homogeneous dose escalation that led to improved local control for small tumors. However, the normal tissue component of large tumors often prohibits homogeneous dose escalation. A newer concept of dose-painting IMRT is aimed at exploiting inhomogeneous dose distributions adapted to tumor heterogeneity. Tumor regions of increased radiation resistance receive escalated dose levels, whereas radiation-sensitive regions receive conventional or even de-escalated dose levels. Dose painting relies on biologic imaging such as positron emission tomography, functional magnetic resonance imaging, and magnetic resonance spectroscopy. This review will describe the competing techologies for dose painting with an emphasis on their commonalities.

Entities:  

Mesh:

Year:  2007        PMID: 17350940     DOI: 10.1200/JCO.2007.10.6716

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  19 in total

1.  Non-invasive MR assessment of macroscopic and microscopic vascular abnormalities in the rectal tumour-surrounding mesorectum.

Authors:  Ewelina Kluza; Jean-Paul J E Kleijnen; Milou H Martens; Dorit Rennspiess; Monique Maas; Cécile R L P N Jeukens; Robert G Riedl; Axel zur Hausen; Geerard L Beets; Regina G H Beets-Tan
Journal:  Eur Radiol       Date:  2015-08-30       Impact factor: 5.315

2.  Evaluating the four-dimensional cone beam computed tomography with varying gantry rotation speed.

Authors:  S A Yoganathan; K J Maria Das; Shajahan Mohamed Ali; Arpita Agarwal; Surendra P Mishra; Shaleen Kumar
Journal:  Br J Radiol       Date:  2016-02-26       Impact factor: 3.039

Review 3.  Imaging hypoxia to improve radiotherapy outcome.

Authors:  Michael R Horsman; Lise Saksø Mortensen; Jørgen B Petersen; Morten Busk; Jens Overgaard
Journal:  Nat Rev Clin Oncol       Date:  2012-11-13       Impact factor: 66.675

Review 4.  (18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications.

Authors:  Gianpiero Manca; Eleonora Vanzi; Domenico Rubello; Francesco Giammarile; Gaia Grassetto; Ka Kit Wong; Alan C Perkins; Patrick M Colletti; Duccio Volterrani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-19       Impact factor: 9.236

Review 5.  Improving radiation conformality in the treatment of non-small cell lung cancer.

Authors:  Joe Y Chang; James D Cox
Journal:  Semin Radiat Oncol       Date:  2010-07       Impact factor: 5.934

Review 6.  Validation of functional imaging as a biomarker for radiation treatment response.

Authors:  C Jentsch; B Beuthien-Baumann; E G C Troost; G Shakirin
Journal:  Br J Radiol       Date:  2015-05-29       Impact factor: 3.039

Review 7.  Intensity-modulated radiotherapy, not 3 dimensional conformal, is the preferred technique for treating locally advanced lung cancer.

Authors:  Joe Y Chang
Journal:  Semin Radiat Oncol       Date:  2014-11-15       Impact factor: 5.934

Review 8.  Intensity-modulated radiotherapy for head and neck surgeons.

Authors:  Stanley I Gutiontov; Edward J Shin; Benjamin Lok; Nancy Y Lee; Ruben Cabanillas
Journal:  Head Neck       Date:  2015-12-26       Impact factor: 3.147

Review 9.  Targeted radiotherapy with gold nanoparticles: current status and future perspectives.

Authors:  Wilfred Ngwa; Rajiv Kumar; Srinivas Sridhar; Houari Korideck; Piotr Zygmanski; Robert A Cormack; Ross Berbeco; G Mike Makrigiorgos
Journal:  Nanomedicine (Lond)       Date:  2014-05       Impact factor: 5.307

10.  CT-based dose recalculations in head and neck cancer radiotherapy: comparison of daily dose recalculations to less time-consuming approaches.

Authors:  Simon Wagenblast; Severin Kampfer; Kai J Borm; Stephanie E Combs; Steffi U Pigorsch; Marciana-Nona Duma
Journal:  Strahlenther Onkol       Date:  2018-12-06       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.